COL4A4

collagen type IV alpha 4 chain, the group of Collagens

Basic information

Region (hg38): 2:227002714-227164453

Links

ENSG00000081052NCBI:1286OMIM:120131HGNC:2206Uniprot:P53420AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal dominant Alport syndrome (Supportive), mode of inheritance: AD
  • autosomal recessive Alport syndrome (Supportive), mode of inheritance: AR
  • autosomal recessive Alport syndrome (Strong), mode of inheritance: AR
  • hematuria, benign familial, 1 (Strong), mode of inheritance: AD
  • Alport syndrome (Definitive), mode of inheritance: Semidominant
  • autosomal recessive Alport syndrome (Definitive), mode of inheritance: AR
  • autosomal recessive Alport syndrome (Definitive), mode of inheritance: AR
  • hematuria, benign familial, 1 (Strong), mode of inheritance: AD
  • autosomal recessive Alport syndrome (Strong), mode of inheritance: AR
  • autosomal recessive Alport syndrome (Definitive), mode of inheritance: AR
  • hematuria, benign familial, 1 (Moderate), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Alport syndrome 2, autosomal recessiveAD/AROphthalmologic; RenalIn Alport syndrome, medical treatment related to renal sequelae (eg, with ACE inhibitors, ARBs) may be beneficial related to delaying renal failure, as well as with overall life expectancy, though dialysis/renal transplantation may be required; Corneal protection may be beneficial in individuals with recurrent corneal erosionsAudiologic/Otolaryngologic; Ophthalmologic; Renal7033680; 7987396; 7783412; 8787673; 9195222; 20301386; 22166847; 22237748; 22811928; 22997344

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the COL4A4 gene.

  • not_provided (2444 variants)
  • Autosomal_recessive_Alport_syndrome (936 variants)
  • Hematuria,_benign_familial,_1 (529 variants)
  • Alport_syndrome (433 variants)
  • Inborn_genetic_diseases (202 variants)
  • not_specified (202 variants)
  • Benign_familial_hematuria (190 variants)
  • COL4A4-related_disorder (128 variants)
  • Autosomal_dominant_Alport_syndrome (92 variants)
  • Hematuria (20 variants)
  • Kidney_disorder (19 variants)
  • Focal_segmental_glomerulosclerosis (13 variants)
  • Glomerulonephritis (4 variants)
  • Meniere_disease (4 variants)
  • Hypertensive_disorder (4 variants)
  • Nephrotic_syndrome (4 variants)
  • Chronic_kidney_disease (3 variants)
  • Hearing_impairment (3 variants)
  • Disease_of_glomerular_basement_membrane (3 variants)
  • Microscopic_hematuria (3 variants)
  • Atypical_hemolytic-uremic_syndrome (2 variants)
  • Myopia (2 variants)
  • Hyperkalemia (2 variants)
  • Thrombocytopenia (2 variants)
  • Stage_5_chronic_kidney_disease (2 variants)
  • Proteinuria (2 variants)
  • Diffuse_mesangial_sclerosis (1 variants)
  • Autosomal_dominant_COL4A4-related_disorders (1 variants)
  • Steroid-resistant_nephrotic_syndrome (1 variants)
  • X-linked_Alport_syndrome (1 variants)
  • Kidney_damage (1 variants)
  • Porencephaly_2 (1 variants)
  • See_cases (1 variants)
  • Polycystic_kidney_disease (1 variants)
  • Usher_syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the COL4A4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000092.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
10
clinvar
24
clinvar
732
clinvar
7
clinvar
775
missense
29
clinvar
321
clinvar
694
clinvar
135
clinvar
7
clinvar
1186
nonsense
50
clinvar
64
clinvar
114
start loss
0
frameshift
153
clinvar
142
clinvar
5
clinvar
300
splice donor/acceptor (+/-2bp)
25
clinvar
119
clinvar
14
clinvar
158
Total 259 656 737 867 14

Highest pathogenic variant AF is 0.000362591

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
COL4A4protein_codingprotein_codingENST00000396625 47161403
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1247000941247940.000377
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.028749630.9080.000050410509
Missense in Polyphen220244.170.901022513
Synonymous-1.183733451.080.00001973775
Loss of Function4.494084.50.4730.000003871113

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007900.000778
Ashkenazi Jewish0.0001990.000199
East Asian0.0002790.000278
Finnish0.00004650.0000464
European (Non-Finnish)0.0004700.000459
Middle Eastern0.0002790.000278
South Asian0.0004590.000458
Other0.0004950.000495

dbNSFP

Source: dbNSFP

Function
FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen.;
Disease
DISEASE: Alport syndrome, autosomal recessive (APSAR) [MIM:203780]: A syndrome characterized by progressive glomerulonephritis, glomerular basement membrane defects, renal failure, sensorineural deafness and specific eye abnormalities (lenticonous and macular flecks). The disorder shows considerable heterogeneity in that families differ in the age of end-stage renal disease and the occurrence of deafness. {ECO:0000269|PubMed:7987396, ECO:0000269|PubMed:9792860}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hematuria, benign familial (BFH) [MIM:141200]: An autosomal dominant condition characterized by non-progressive isolated microscopic hematuria that does not result in renal failure. It is characterized pathologically by thinning of the glomerular basement membrane. {ECO:0000269|PubMed:11961012, ECO:0000269|PubMed:12631110, ECO:0000269|PubMed:8787673}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
PI3K-Akt signaling pathway - Homo sapiens (human);ECM-receptor interaction - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Relaxin signaling pathway - Homo sapiens (human);AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human);Small cell lung cancer - Homo sapiens (human);Protein digestion and absorption - Homo sapiens (human);Amoebiasis - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Platelet Aggregation Inhibitor Pathway, Pharmacodynamics;Primary Focal Segmental Glomerulosclerosis FSGS;Focal Adhesion;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;Protein alkylation leading to liver fibrosis;PI3K-Akt Signaling Pathway;EMT transition in Colorectal Cancer;Developmental Biology;Assembly of collagen fibrils and other multimeric structures;Signal Transduction;regulators of bone mineralization;intrinsic prothrombin activation pathway;Collagen chain trimerization;Collagen biosynthesis and modifying enzymes;Integrin cell surface interactions;Signaling by PDGF;Collagen formation;Extracellular matrix organization;Beta3 integrin cell surface interactions;Integrin;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Signaling by Receptor Tyrosine Kinases;Beta1 integrin cell surface interactions;Syndecan-1-mediated signaling events;Integrins in angiogenesis (Consensus)

Recessive Scores

pRec
0.249

Intolerance Scores

loftool
0.0825
rvis_EVS
1.04
rvis_percentile_EVS
91.27

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0237

Gene Damage Prediction

AllRecessiveDominant
MendelianHighMediumHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Gene ontology

Biological process
angiogenesis;endothelial cell morphogenesis;extracellular matrix organization;glomerular basement membrane development
Cellular component
extracellular region;collagen type IV trimer;basement membrane;extracellular space;endoplasmic reticulum lumen;extracellular matrix
Molecular function
extracellular matrix structural constituent
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.